tirzepatide thyroid and cancer Evaluating Thyroid Cancer Risk After GLP-1 Receptor Agonist Administration Do Semaglutide or Tirzepatide cause

Lastly, for those who are eligible, metabolic/bariatric surgery should remain part of the conversation, as it is one of the most effective and durable obesity treatments we have

GLP-1 medications may be contraindicated if you have or have a history of: personal and family history of papillary and follicular thyroid cancers (given that there may be an increased risk based on animal studies) chronic nausea, vomiting or gastroparesis (as GLP-1s slow down gastric emptying and may worsen GI symptoms) pancreatitis (GLP-1s may increase the risk of pancreatitis or inflammation of the pancreas) children under 12 years old currently pregnant or breastfeeding eating disorders allergy or hypersensitivity to the medication weight cycling (losing and gaining weight back) without needing to lose weight for health reasons Always consult a healthcare professional before starting GLP-1 medications to ensure they align with your health needs and treatment plan

Visible weight loss typically becomes apparent by the end of the first month

10.1016/j.bj.2025.100849 Biomed

For a broader introduction to stacking concepts, safety rules, and how to plan multi-compound protocols, see the Peptide Stacking 101 guide on PepPal